(Q45733739)

English

Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation

scientific article published in March 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perforin pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Epstein–Barr virus

0 references

0 references

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

author name string

Ayami Yoshimi

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Ikuya Tsuge

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hiroe Namizaki

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Yo Hoshino

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hiroshi Kimura

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Yoshiyuki Takahashi

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Nobuhiro Watanabe

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Kiyotaka Kuzushima

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Seiji Kojima

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

710-715

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL-2 production

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

How do cytotoxic lymphocytes kill their targets?

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03299.X

21 January 2018

Identifiers

10.1046/J.0007-1048.2001.03299.X

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45733739&oldid=2079061264"